Biotech news continually updated from thousands of sources around the net.
A drug for type two diabetes is still being prescribed in the UK despite being recommended for withdrawal two months ago, BBC Panorama has found.
Flu-shot season is here, and for the first time, health leaders are encouraging nearly everyone to get vaccinated.
Research by DNA fingerprinting pioneer and his team at University of Leicester defines engine for change in genetic hotspots One of the key drivers of human evolution and diversity, accounting for changes that occur between different generations of people, is explained by new research published today by world-renowned scientist Professor Sir Alec ...
Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
Global Health Progress supports MMV's decision to contribute its intellectual property.
Take a university professor with a gambling problem, the boss of a homeless shelter, a prostitute, a red-hot political issue such as pro-life versus pro-choice, and add a powerful pharmaceutical corporation.
Posted By: Lauren Lombardi "It's been a long night in Salt Lake too," sang John Mayer last night at USANA Amphitheatre, but fans would argue it wasn't long enough.
The health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives of the bill - and calling for further government efforts to help pharmaceutical research and development.
Oxygen Biotherapeutics, Inc. , a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced that the company will report first quarter fiscal year 2011 financial results following the close of the U.S. financial markets on Thursday, September 9, 2010.
Bausch + Lomb, the global eye health company, has announced that it has concluded its acquisition of a portion of the assets and intellectual property for Miochol -E from Affiliates of Novartis AG.
Shire plc has launched a Facebook page in honor of National Gaucher Awareness Month - a move designed to link the name of the company, and the name of the rare disease its drug, VPRIV, is treating.
A biotechnology company's genetically engineered salmon are as safe to eat as other Atlantic salmon, U.S. regulators said as they weighed approval of the first DNA-altered animal for Americans' dinner plates.
Bharat Mehrotra, director of Bioinformatics, demonstrated how he collects samples to determine whether DNA biomarkers are present.
Arizona Gov. Jan Brewer speaks to reporters outside the White House in Washington, Thursday, June 3, 2010, after a private meeting with President Barack Obama.
Joseph Garner leads one of the most recent UAB spinoffs, Soluble Therapeutics. Research findings from the University of Alabama at Birmingham recently spawned a biotechnology firm specializing in protein-based drugs and vaccines.
Drug and medical device firm Abbott Laboratories says it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies.
Halozyme Therapeutics, Inc. announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog, and insulin lispro, the active ingredient in Humalog.
Botox maker Allergan Inc. said Wednesday that it would pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
REDWOOD SHORES, Calif. a " A small plane that crashed into a shallow lagoon off San Francisco Bay on Thursday, killing three people, belonged to the founder of a local steel company who was believed to be among the dead.An employee of R.E. Borrmann's Steel Co.
In the United States, high blood pressure causes about one third of new cases of kidney failure.